Search results
AMD STOPPER Offers New Hope to Sufferers of Age-Related Macular Degeneration | Healthcare Dive
Healthcare Dive· 2 days agoFearful of losing all of his central vision to the gradual blinding effects of Age-Related Macular Degeneration (AMD), a California-based researcher with ...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
Coronado Eagle & Journal· 1 day agoHospital in Ústí nad Labem in the Czech Republic, have unveiled groundbreaking findings from a study showcasing the effectiveness of the Somavedic device in supporting individuals with wet age-related ...
The murky, unregulated world of anti-ageing stem cell therapy
The Telegraph via Yahoo News· 7 hours agoStem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 hours agoStargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight PR Newswire LAS VEGAS, April 24, 2024 The expected launch of potential therapies may increase the Stargardt disease market size in the coming years, assisted by an
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 7 days agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
Toppling Goliath Brewing Co. partners with BREWS for BLiNDNESS
The Hannibal Courier-Post· 6 days agoToppling Goliath Brewing Co. has partnered with Iowa based Non-Profit BREWS for BLiNDNESS to support...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Morningstar· 7 days ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoMoreover, its planned launch of aflibercept—for patients living with wet macular degeneration—could be a potentially significant biosimilar opportunity,...
I Can See Clearly Now: Eye Care for Seniors Begins at 50 - The Baltimore Times
Baltimore Times· 5 days agoIf you can recall the Johnny Nash 70’s chart-topping hit “I Can See Clearly Now” or grew up watching...
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2...
Morningstar· 6 days agoGA affects approximately 1 million people in the United States alone.
